http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101424514-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate | 2013-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101424514-B1 |
| titleOfInvention | Memantine as a therapeutic treatment of fetal valproate syndrome |
| abstract | The present invention relates to memantine, a substance for treating social deficit symptoms, and more particularly, to a treatment for psychiatric diseases, wherein the NMDA receptor antagonist memantine effectively treats the symptoms of sociability deficiency and convulsive sensitivity increase in congenital valproic acid exposure syndrome Can be used. |
| priorityDate | 2013-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 71.